Contact  |  Sign Up
logo

Ibrahim Abubakar

TB MAC Advisory Panel

Director of UCL Institute for Global Health

He led the UCL Centre for Infectious Disease Epidemiology, UCL-TB and was a senior investigator at the MRC Clinical Trials Unit. He was head of TB at Public Health England. Prior to his appointment at UCL, he was Professor in Health Protection at the Norwich Medical School. He qualified in medicine in 1992 and initially trained in general medicine before specialising in public health medicine. His academic public health training was undertaken at the London School of Hygiene and Tropical Medicine, University of Cambridge and the University of East Anglia. He serves on/chairs several expert/advisory groups for the WHO and the European Centre for Disease Prevention and Control.

Sevim Ahmedov

TB MAC Advisory Panel

Senior TB Technical Advisor at USAID (United States Agency for International Development)

Liz Corbett

photo
TB MAC Advisory Panel

Wellcome Trust Senior Fellow / Clinical Epidemiologist

Liz Corbett is a Wellcome Trust Senior Fellow and a Clinical Epidemiologist with the London School of Hygiene and Tropical Medicine, based full time in Blantyre, Malawi. Her main research interests concern control of TB in HIV prevalent populations from the public health perspective, with a focus on the epidemiology at primary care and community level, and intervention trials. She is a member of the Strategic and Technical Advisory Group for the TB Programme of the World Health Organization. Her research has highlighted the public health importance of undiagnosed infectious TB and community-level interventions providing access to TB and HIV diagnosis.  She has ongoing research in self-testing for HIV, management of smear-negative TB suspects, TB diagnostic evaluation, and in the epidemiology of adolescent long-term survivors of mother-to-child transmission of HIV infection

Philippe Glaziou

photo
TB MAC Advisory Panel

Philippe Glaziou is team leader in charge of epidemiological analyses of the burden of TB, the impact of TB control and global projections of TB burden, at the Stop TB Department of the World Health Organization in Geneva.  He is a medical doctor and holds post-graduate degrees in biostatistics, clinical trials methodology, epidemiology, tropical medicine and public health from the Universiities Paris VI, Bordeaux and Nancy.  Prior to joining WHO in 2004, he was employed by the Institute Pasteur in Paris, posted internationally as Laboratory head in several Pasteur Institutes.  His current area of interest is disease burden estimation

Johannes Hunger

photo
TB MAC Advisory Panel

Head of Strategic Information, The Global Fund to Fight AIDS, Tuberculosis and Malaria

Mr. Johannes Hunger has been the Head of Strategic Information at The Global Fund to Fight AIDS, Tuberculosis and Malaria since October 27, 2014. Mr. Hunger joined the Global Fund in 2007 as a Senior Strategy and Policy Officer. He then served as Senior Policy Analyst, Senior Manager in Strategy and Policy, and most recently as the acting Head of Strategy and Policy in the Office of the Executive Director. He has also served as senior focal point for Global Fund Partners, including the European Commission, GAVI and the International Health Partnership IHP+. Before joining the Global Fund, Mr. Hunger worked for the Boston Consulting Group, where he lead an international project team at the UN World Food Program and managed international projects with a focus on development and implementation of growth and investment strategies. He has written several articles on innovative modelling approaches in chemistry and on the philosophy of science. Mr. Hunger has a Master's Degree in analytical philosophy from the University of Bielefeld as well as a Master of Science and a PhD in chemistry with a focus on statistical modelling and drug design from the University of Heidelberg.

Carol Levin

TB MAC Advisory Panel

Dr. Carol Levin is an expert in costing health technologies and interventions delivered in public health delivery systems. Currently, she is the director for the Global Health Cost Consortium to strengthen access to, and the use of, high quality cost data for HIV and TB. Previously, she led the systematic review of costs of global health interventions as part of the Disease Control Priorities Project. Her interests are in conducting research on the costs and cost-effectiveness of introducing and scaling up public health interventions related to maternal, reproductive and child health and HIV. She has also recently conducted research on the costs of domestic programs in the US, recently completing work with colleagues at UW Department of Psychiatry to estimate the cost of initiatives in the Washington State mental health program. In addition to health economics, she is also an expert in the area of food security and nutrition policy, where most recently she focused on implementing and evaluating an integrated agriculture and health project to maximize health and nutrition outcomes. She was also a contributing author to the 2015 Global Nutrition Report on defining healthy food systems.

Adam MacNeil

TB MAC Advisory Panel

Adam MacNeil, PhD, MPH, is the staff epidemiologist for the Special Pathogens Branch within CDC’s proposed new National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) in Atlanta. The primary focus of his work in the Special Pathogens Branch is on surveillance and epidemiology of high-hazard zoonotic viruses. He has a PhD from the Department of Immunology and Infectious Diseases at Harvard University and an MPH in epidemiology from the University of Michigan.

Before joining the Special Pathogens Branch, Dr. MacNeil was an Epidemic Intelligence Service (EIS) officer at CDC and was involved in multiple international outbreak investigations, including Ebola hemorrhagic fever in Uganda, monkeypox in the Democratic Republic of Congo, and atypical Varicella zoster virus infection in the Republic of the Congo.

Jeremiah Chakaya Muhwa

TB MAC Advisory Panel

Dr Chakaya has been a leader in tuberculosis (TB) control throughout his career, in his home country of Kenya and on the global stage. Until recently the Chief Research Officer for the Kenya Medical Research Institute, he has led the National TB Control Programme as its head from 2003 to 2006 and continues to act as a technical expert for the National Programme. In Kenya he also acts as the technical advisor and director of the Kenya Association Against TB and Lung Disease (KAPTLD). As a founding member of KAPTLD he has steered this organisation to be a leader in TB control, focusing particularly on TB and poverty in urban slums of Kenya as well as Public Private partnerships in TB control.

On an international stage, Dr Chakaya has been active in both the Stop TB partnership and at the World Health Organization (WHO). He has served three terms as the chair of the DOTS Expansion Working Group of the STOP TB Partnership as well as chair of STAG TB at WHO. Respected for his work and knowledge about the region, he has participated in a variety of country and programmatic reviews throughout Africa. A passionate teacher, Dr Chakaya remains the leading force behind such initiatives as the Kenya Scientific Lung Conference and remains a prolific scientific writer. Dr Chakaya is taking up a teaching, research and clinical position at the school of medicine Kenyatta University after many years of work with the Kenya Medical Research Institute. 

Sahu Suvanand

TB MAC Advisory Panel

Deputy Executive Secretary of Stop TB Partnership

David Wilson

photo
TB MAC Advisory Panel

David - Senior Program Officer in Decision Sciences at the Bill & Melinda Gates Foundation.

Prior to joining the Foundation, David was a Professor of Modeling & Health Economics at the Burnet Institute and Monash University in Australia, and CEO of the Optima Consortium for Decision Science, where he was leading teams conducting applied research into improving efficiency in health responses. In 17 years as an academic prior to joining the Gates Foundation, his dominant focus was on allocative efficiency for major infectious diseases (with special focus on HIV) although has also worked in other areas of health and complementary methods. This includes, for six years being the Head of Public Health Surveillance in Australia for blood-borne viruses and STIs. Most of his work has been conducted to support LMIC governments and their local or global partners to make better decisions for health through the generation, synthesis and promotion of quantitative evidence including surveillance, modeling, health economics and resource allocation, strategic target setting, supporting strategic purchasing and financing, and capacity building in countries for the translation of evidence to policy and programming. Working in approximately 40 countries on all continents, he has published over 230 scientific papers and delivered over 500 scientific addresses.

David Wilson

TB MAC Advisory Panel

Global AIDS Program Director

David Wilson is the World Bank's Global AIDS Program Director and was previously the Bank's Lead HIV Specialist. His work on HIV/AIDS spans almost 25 years. During his career he has worked as a scientist and program manager in more than 50 countries and has published approximately 100 scientific papers. His interests lie in HIV epidemiology, HIV prevention science and program evaluation. He has developed prevention programs that have been recognized as best practice by the World Bank, WHO and DFID, and have been influential in international HIV prevention science. In addition, he has served as technical consultant and adviser to many international agencies, including USAID, DFID, EU, AUSAID, SIDA, NORAD, UNAIDS, UNICEF and WHO.